Silodosin vs naftopidilQoL1 finding from 1 reviewSilodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 652 participantsLow